Immanuel Thangaraj, Managing Director, Essex Woodlands Health Ventures
Immanuel. Thangaraj has 15 years of experience in operations and venture capital. Mr. Thangaraj began his venture career at ARCH Venture Partners (AVP), a leading venture capital firm with over $1 billion under management. In his initial tenure at AVP, which makes early stage technology and healthcare investments, he managed one of its portfolio companies until its sale to a large hospital supplies company. In 1995, Mr. Thangaraj left AVP to run a telecommunications company until its sale to a public company.
Mr. Thangaraj joined Essex Woodlands in 1997. He currently serves on the Board of Directors of CBR Systems, Acura Pharmaceuticals (formerly Halsey Pharmaceuticals), Clear Vascular, Proteus and Medlogics. He is also responsible for Essex Woodland’s investments in Accumetrics and Novacept (sold to Cytyc).
Mr. Thangaraj holds a Bachelor of Arts and a Masters in Business Administration from the University of Chicago.
Founder
VP of Corporate Development, Covidien
Chairman,
Henry Crown and Company
President and CEO
Member, MedVenture Associates
Partner, US Venture Partners
Immanuel Thangaraj
Managing Director, Essex Woodlands
Health Ventures
Senior Partner,
Wilson, Sonsini, Goodrich & Rosati
Director of Finance
